Exome Asset Management LLC 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Exome Asset Management LLC disclosed 54 US equity positions worth $151.4m in its Q3 2025 13F filing. The largest position was IONS at 5.7% of the reported book, followed by CYTK and BBIO. Against the Q2 2025 filing, it opened 19 new positions, added to 10 and reduced 11 among the top 50 holdings.
What did Exome Asset Management LLC own in Q3 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 5.7% | $8.6m | 131,016 | 8% | added |
| 2 | CYTK CYTOKINETICS INC | Healthcare | 5.2% | $7.8m | 142,417 | 23% | added |
| 3 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 4.6% | $6.9m | 133,087 | -14% | reduced |
| 4 | COGT COGENT BIOSCIENCES INC | Healthcare | 4.2% | $6.4m | 443,547 | -17% | reduced |
| 5 | GH GUARDANT HEALTH INC | Healthcare | 4.1% | $6.1m | 98,182 | 0% | held |
| 6 | LLY ELI LILLY & CO | Healthcare | 4.0% | $6.0m | 7,852 | 68% | added |
| 7 | NBP I MAB | Healthcare | 3.6% | $5.4m | 1,439,604 | – | new |
| 8 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 3.6% | $5.4m | 101,996 | 73% | added |
| 9 | VERA VERA THERAPEUTICS INC | Healthcare | 3.0% | $4.5m | 156,072 | 103% | added |
| 10 | AZN ASTRAZENECA PLC | Healthcare | 2.8% | $4.3m | 28,362 | – | new |
| 11 | IRON DISC MEDICINE INC | Healthcare | 2.7% | $4.1m | 61,356 | 0% | held |
| 12 | ETNBGBP 89BIO INC | 2.7% | $4.0m | 273,661 | 17% | added | |
| 13 | APGE APOGEE THERAPEUTICS INC | Healthcare | 2.5% | $3.8m | 94,400 | – | new |
| 14 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 2.5% | $3.8m | 156,917 | 2% | added |
| 15 | THC TENET HEALTHCARE CORP | Healthcare | 2.4% | $3.7m | 18,100 | -33% | reduced |
| 16 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 2.4% | $3.6m | 104,507 | – | new |
| 17 | CVS CVS HEALTH CORP | Healthcare | 2.2% | $3.3m | 43,600 | – | new |
| 18 | SLNOEUR SOLENO THERAPEUTICS INC | 2.2% | $3.3m | 48,445 | 16% | added | |
| 19 | NTRA NATERA INC | Healthcare | 2.0% | $3.0m | 18,650 | 0% | held |
| 20 | CRBP CORBUS PHARMACEUTICALS HLDGS | Healthcare | 1.9% | $2.9m | 229,962 | -17% | reduced |
| 21 | ISRG INTUITIVE SURGICAL INC | Healthcare | 1.9% | $2.8m | 6,358 | 0% | held |
| 22 | EWTX EDGEWISE THERAPEUTICS INC | 1.9% | $2.8m | 173,439 | 39% | added | |
| 23 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 1.8% | $2.8m | 6,645 | – | new |
| 24 | AKERO THERAPEUTICS INC | 1.8% | $2.8m | 58,579 | – | new | |
| 25 | IMVT IMMUNOVANT INC | Healthcare | 1.7% | $2.6m | 158,622 | – | new |
| 26 | GERN GERON CORP | Healthcare | 1.7% | $2.5m | 1,858,354 | -46% | reduced |
| 27 | CTMX CYTOMX THERAPEUTICS INC | Healthcare | 1.6% | $2.4m | 745,305 | – | new |
| 28 | PEN PENUMBRA INC | Healthcare | 1.5% | $2.3m | 9,000 | 0% | held |
| 29 | GKOS GLAUKOS CORP | Healthcare | 1.5% | $2.2m | 27,143 | – | new |
| 30 | LQDA LIQUIDIA CORPORATION | Healthcare | 1.4% | $2.1m | 94,235 | 360% | added |
| 31 | CNTA CENTESSA PHARMACEUTICALS PLC | 1.4% | $2.1m | 88,024 | -47% | reduced | |
| 32 | TXG 10X GENOMICS INC | Healthcare | 1.3% | $1.9m | 163,658 | 0% | held |
| 33 | COR CENCORA INC | Healthcare | 1.2% | $1.9m | 6,000 | – | new |
| 34 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 1.2% | $1.8m | 117,783 | -62% | reduced |
| 35 | WAY WAYSTAR HLDG CORP | Healthcare | 1.2% | $1.8m | 46,900 | 0% | held |
| 36 | SRPT SAREPTA THERAPEUTICS INC | 1.2% | $1.8m | 2,000,000 | 0% | held | |
| 37 | KARYOPHARM THERAPEUTICS INC | 1.1% | $1.6m | 2,000,000 | 0% | held | |
| 38 | UHS UNIVERSAL HLTH SVCS INC | Healthcare | 1.1% | $1.6m | 7,955 | -21% | reduced |
| 39 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 1.0% | $1.4m | 120,644 | – | new |
| 40 | PRCT PROCEPT BIOROBOTICS CORP | Healthcare | 0.9% | $1.4m | 39,900 | – | new |
| 41 | INSP INSPIRE MED SYS INC | Healthcare | 0.9% | $1.4m | 18,600 | – | new |
| 42 | QURE UNIQURE NV | 0.9% | $1.3m | 22,090 | – | new | |
| 43 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 0.8% | $1.3m | 178,084 | – | new |
| 44 | AVTX AVALO THERAPEUTICS INC | Healthcare | 0.8% | $1.3m | 100,036 | – | new |
| 45 | GOSS GOSSAMER BIO INC | Healthcare | 0.8% | $1.2m | 451,699 | -59% | reduced |
| 46 | ALMS ALUMIS INC | 0.8% | $1.2m | 292,770 | – | new | |
| 47 | UPB UPSTREAM BIO INC | 0.6% | $977.4k | 51,960 | – | new | |
| 48 | MBX MBX BIOSCIENCES INC | Healthcare | 0.6% | $917.0k | 52,402 | -17% | reduced |
| 49 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 0.6% | $909.0k | 98,799 | -78% | reduced |
| 50 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 0.4% | $537.0k | 13,100 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.